These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 31181727)

  • 81. The role of actinin-4 (ACTN4) in exosomes as a potential novel therapeutic target in castration-resistant prostate cancer.
    Ishizuya Y; Uemura M; Narumi R; Tomiyama E; Koh Y; Matsushita M; Nakano K; Hayashi Y; Wang C; Kato T; Hatano K; Kawashima A; Ujike T; Fujita K; Imamura R; Adachi J; Tomonaga T; Nonomura N
    Biochem Biophys Res Commun; 2020 Mar; 523(3):588-594. PubMed ID: 31941606
    [TBL] [Abstract][Full Text] [Related]  

  • 82. PCK1 regulates neuroendocrine differentiation in a positive feedback loop of LIF/ZBTB46 signalling in castration-resistant prostate cancer.
    Wen YC; Liu CL; Yeh HL; Chen WH; Jiang KC; Tram VTN; Hsiao M; Huang J; Chen WY; Liu YN
    Br J Cancer; 2022 Mar; 126(5):778-790. PubMed ID: 34815524
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Epithelial-Mesenchymal Transition Signaling and Prostate Cancer Stem Cells: Emerging Biomarkers and Opportunities for Precision Therapeutics.
    Chaves LP; Melo CM; Saggioro FP; Reis RBD; Squire JA
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946849
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Understanding Mechanisms of Resistance in Metastatic Castration-resistant Prostate Cancer: The Role of the Androgen Receptor.
    Tilki D; Schaeffer EM; Evans CP
    Eur Urol Focus; 2016 Dec; 2(5):499-505. PubMed ID: 28723515
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A FOXC2 inhibitor, MC-1-F2, as a therapeutic candidate for targeting EMT in castration-resistant prostate cancer.
    Castaneda M; Rodriguez L; Oh J; Cagle-White B; Suh H; Abdel Aziz MH; Lee J
    Bioorg Med Chem Lett; 2023 Jul; 91():129369. PubMed ID: 37290495
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Influence of ADT on B7-H3 expression during CRPC progression from hormone-naïve prostate cancer.
    Kang N; Xue H; Lin YY; Dong X; Classen A; Wu R; Jin Y; Lin D; Volik S; Ong C; Gleave M; Collins C; Wang Y
    Cancer Gene Ther; 2023 Oct; 30(10):1382-1389. PubMed ID: 37452083
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Genetically Engineered Membrane-Coated Nanoparticles for Enhanced Prostate-Specific Membrane Antigen Targeting and Ferroptosis Treatment of Castration-Resistant Prostate Cancer.
    Li Y; Li H; Zhang K; Xu C; Wang J; Li Z; Zhou Y; Liu S; Zhao X; Li Z; Yang F; Hu W; Jing Y; Wu P; Zhang J; Shi C; Zhang R; Jiang W; Xing N; Wen W; Han D; Qin W
    Adv Sci (Weinh); 2024 Sep; 11(33):e2401095. PubMed ID: 38946578
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Role of the runt-related transcription factor (RUNX) family in prostate cancer.
    Ashe H; Krakowiak P; Hasterok S; Sleppy R; Roller DG; Gioeli D
    FEBS J; 2021 Nov; 288(21):6112-6126. PubMed ID: 33682350
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate Cancer.
    Cancers (Basel); ; . PubMed ID: 28264478
    [TBL] [Abstract][Full Text] [Related]  

  • 90.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 91.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 92.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 93.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.